2487 related articles for article (PubMed ID: 8093465)
21. Abnormal clinical pharmacokinetics of the developmental radiosensitizers pimonidazole (Ro 03-8799) and etanidazole (SR 2508).
Maughan TS; Newman HF; Bleehen NM; Ward R; Workman P
Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1151-6. PubMed ID: 2140825
[TBL] [Abstract][Full Text] [Related]
22. Radiosensitization by 2-nitroimidazole nucleoside analog RP-170: radiosensitizing effects under both intravenous and oral administration.
Murayama C; Suzuki A; Sato C; Tanabe Y; Miyata Y; Shoji T; Suzuki T; Sakaguchi M; Mori T
Int J Radiat Oncol Biol Phys; 1992; 22(3):557-60. PubMed ID: 1531214
[TBL] [Abstract][Full Text] [Related]
23. Distribution of etanidazole into human brain tumors: implications for treating high grade gliomas.
Hurwitz SJ; Coleman CN; Riese N; Loeffler JS; Alexander E; Buswell L; Neben TY; Shargel L; Kramer RA
Int J Radiat Oncol Biol Phys; 1992; 22(3):573-6. PubMed ID: 1531216
[TBL] [Abstract][Full Text] [Related]
24. In vivo radiosensitization efficacy of KU-2285 and etanidazole at clinically relevant low radiation doses.
Oya N; Shibamoto Y; Sasai K; Sugiyama T; Abe M
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1113-9. PubMed ID: 8262836
[TBL] [Abstract][Full Text] [Related]
25. Atrasentan (ABT-627) enhances perfusion and reduces hypoxia in a human tumor xenograft model.
Yang KM; Russell J; Lupu ME; Cho H; Li XF; Koutcher JA; Ling CC
Cancer Biol Ther; 2009 Oct; 8(20):1940-6. PubMed ID: 19717985
[TBL] [Abstract][Full Text] [Related]
26. Optical isomers of a new 2-nitroimidazole nucleoside analog (PR-350 series): radiosensitization efficiency and toxicity.
Oya N; Shibamoto Y; Sasai K; Shibata T; Murata R; Takagi T; Iwai H; Suzuki T; Abe M
Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):119-27. PubMed ID: 7642409
[TBL] [Abstract][Full Text] [Related]
27. Effect of pH, oxygenation, and temperature on the cytotoxicity and radiosensitization by etanidazole.
Teicher BA; Herman TS; Holden SA
Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):723-31. PubMed ID: 1825994
[TBL] [Abstract][Full Text] [Related]
28. Importance of antibody concentration in the assessment of cellular hypoxia by flow cytometry: EF5 and pimonidazole.
Koch CJ
Radiat Res; 2008 Jun; 169(6):677-88. PubMed ID: 18494550
[TBL] [Abstract][Full Text] [Related]
29. Radiotherapy using the hypoxic cell sensitizer Ro 03-8799 in malignant melanoma.
Dische S
Radiother Oncol; 1987 Oct; 10(2):111-6. PubMed ID: 2447612
[TBL] [Abstract][Full Text] [Related]
30. Radiosensitization efficacy of KU-2285, RP-170 and etanidazole at low radiation doses: assessment by in vitro cytokinesis-block micronucleus assay.
Shibamoto Y; Streffer C; Sasai K; Oya N; Abe M
Int J Radiat Biol; 1992 Apr; 61(4):473-8. PubMed ID: 1349329
[TBL] [Abstract][Full Text] [Related]
31. The uptake of the radiosensitizing compound Ro 03-8799 (Pimonidazole) in human tumors.
Dische S; Bennett MH; Orchard R; Stratford MR; Wardman P
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1089-92. PubMed ID: 2703388
[TBL] [Abstract][Full Text] [Related]
32. Hypoxic cell radiosensitizers in the treatment of high grade gliomas: a new direction using combined Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole).
Newman HF; Bleehen NM; Ward R; Workman P
Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):677-84. PubMed ID: 2843488
[TBL] [Abstract][Full Text] [Related]
33. A fluorinated 2-nitroimidazole, KU-2285, as a new hypoxic cell radiosensitizer.
Sasai K; Nishimoto S; Shimokawa K; Hisanaga Y; Kitakabu Y; Shibamoto Y; Zhou L; Wang J; Takahashi M; Kagiya T
Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1249-54. PubMed ID: 1828462
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of 2-nitroimidazole hypoxic cell radiosensitizers in rodent peripheral nervous tissue.
Sasai K; Shibamoto Y; Takahashi M; Ito T; Nishimoto S; Abe M
Int J Radiat Biol; 1990 May; 57(5):971-80. PubMed ID: 1970998
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of etanidazole (SR-2508) in bladder and cervical cancer: evidence of diffusion from urine.
Awwad HK; el Badawy S; abd el Baki H; Zaghloul M; el Moneim Osman A; Akoush H; Fairchild K
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1083-4. PubMed ID: 2522918
[TBL] [Abstract][Full Text] [Related]
36. A new, potent 2-nitroimidazole nucleoside hypoxic cell radiosensitizer, RP170.
Sasai K; Shibamoto Y; Takahashi M; Abe M; Wang J; Zhou L; Nishimoto S; Kagiya T
Jpn J Cancer Res; 1989 Nov; 80(11):1113-8. PubMed ID: 2532634
[TBL] [Abstract][Full Text] [Related]
37. Effect of acidic pH on radiosensitization of FSaIIC cells in vitro by misonidazole, etanidazole, or cis-diamminedichloroplatinum (II).
Herman TS; Teicher BA; Pfeffer MR; Khandekar V; Chapnick RM; Kalick GS; Rabow A
Radiat Res; 1990 Oct; 124(1):28-33. PubMed ID: 2146699
[TBL] [Abstract][Full Text] [Related]
38. Photodynamic effects of hypericin on lipid peroxidation and antioxidant status in melanoma cells.
Hadjur C; Richard MJ; Parat MO; Jardon P; Favier A
Photochem Photobiol; 1996 Aug; 64(2):375-81. PubMed ID: 8760577
[TBL] [Abstract][Full Text] [Related]
39. Additivity of radiosensitization by the combination of SR 2508 (etanidazole) and Ro 03-8799 (pimonidazole) in a murine tumor system.
Honess DJ; Wasserman TH; Workman P; Ward R; Bleehen NM
Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):671-5. PubMed ID: 2971028
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of fluorinated 2-nitroimidazole hypoxic cell radiosensitizers in murine peripheral nervous tissue.
Sasai K; Iwai H; Yoshizawa T; Nishimoto S; Shibamoto Y; Kitakabu Y; Oya N; Takahashi M; Abe M
Int J Radiat Biol; 1992 Aug; 62(2):221-7. PubMed ID: 1355516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
